P Gourlet
Overview
Explore the profile of P Gourlet including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
52
Citations
451
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Dahma H, Gourlet P, VANDERMEERS A, Robberecht P
Peptides
. 2001 Aug;
22(9):1491-9.
PMID: 11514034
A rabbit antiserum was raised against a synthetic peptide corresponding to residues 403 to 417 of human chromogranin B. This peptide was chosen to match the potential C-terminal end of...
2.
Juarranz M, Van Rampelbergh J, Gourlet P, Waelbroeck M, Robberecht P
Ann N Y Acad Sci
. 2001 Feb;
921:395-9.
PMID: 11193863
No abstract available.
3.
Moreno D, Gourlet P, De Neef P, Cnudde J, Waelbroeck M, Robberecht P
Peptides
. 2000 Nov;
21(10):1543-9.
PMID: 11068102
Ro 25-1553 is a cyclic VIP derivative with a high affinity for the VPAC(2) receptor subtype. Our goal was to identify the modifications that support its selectivity for VPAC(2) receptors,...
4.
VANDERMEERS A, Gourlet P, Ali M, Waelbroeck M, Robberecht P
Eur J Biochem
. 2000 Jul;
267(14):4556-60.
PMID: 10880980
Six forms of helospectin (a vasoactive intestinal peptide analogue) were purified from the venom of the Heloderma horridum lizard. Their identification was performed by combining sequencing by automated Edman degradation...
5.
Juarranz M, Van Rampelbergh J, Gourlet P, De Neef P, Cnudde J, Robberecht P, et al.
Mol Pharmacol
. 1999 Nov;
56(6):1280-7.
PMID: 10570056
A vasoactive intestinal polypeptide (VIP) analog, acylated on the amino-terminal histidine by hexanoic acid (C(6)-VIP), behaved as a VPAC(2) preferring agonist in binding and functional studies on human VIP receptors,...
6.
Juarranz M, Van Rampelbergh J, Gourlet P, De Neef P, Cnudde J, Robberecht P, et al.
Eur J Biochem
. 1999 Sep;
265(1):449-56.
PMID: 10491203
In order to identify the receptor domains responsible for the VPAC1 selectivity of the VIP1 agonist, [Lys15, Arg16, Leu27] VIP (1-7)/GRF (8-27) and VIP1 antagonist, Ac His1 [D-Phe2, Lys15, Arg16,...
7.
Walraevens V, VANDERMEERS A, Gourlet P, Robberecht P
Biol Chem
. 1999 Jun;
380(4):485-8.
PMID: 10355634
The dried latex of the mountain papaya, Carica candamarcensis, was chromatographed on CM-Sephadex C50, giving rise to three peaks (CCI, CCII and CCIII) with amidase activity on N-alpha-benzoyl-DL-arginine-4-nitroanilide. The less...
8.
Vertongen P, Schiffmann S, Gourlet P, Robberecht P
Ann N Y Acad Sci
. 1999 Feb;
865:412-5.
PMID: 9928040
No abstract available.
9.
Gourlet P, VANDERMEERS A, Van Rampelbergh J, De Neef P, Cnudde J, Waelbroeck M, et al.
Ann N Y Acad Sci
. 1999 Feb;
865:247-52.
PMID: 9928018
Vasoactive intestinal polypeptide (VIP) acts through interaction with two subclasses of seven transmembrane G protein-coupled receptors named VIP1 and VIP2 receptors. These receptors have been cloned in different species, such...
10.
Gourlet P, RATHE J, De Neef P, Cnudde J, Waelbroeck M, Robberecht P
Eur J Pharmacol
. 1998 Sep;
354(1):105-11.
PMID: 9726637
Stearyl vasoactive intestinal polypeptide has been reported to be a VIP (vasoactive intestinal polypeptide) receptor agonist of high potency with an original bioavailability and action. We synthesized three fatty acyl...